Kraig Biocraft Laboratories (KBLB) Return on Equity (2011 - 2025)

Kraig Biocraft Laboratories has disclosed Return on Equity across 13 years of filings, most recently posting 0.0% for Q4 2025.

• Return on Equity for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Equity came in at 0.0% for Q4 2025 at Kraig Biocraft Laboratories, up from 0.0% in the prior quarter.
• In the past five years, Return on Equity ranged from a high of 0.02% in Q1 2022 to a low of 0.0% in Q2 2025.
• The 5-year median for Return on Equity is 0.01% (2023), against an average of 0.01%.
• Peak annual rise in Return on Equity reached 1 bps in 2021, while the deepest fall reached 1 bps in 2021.
• Kraig Biocraft Laboratories' Return on Equity stood at 0.01% in 2021, then slipped by 27 bps to 0.01% in 2022, then sank by 46 bps to 0.01% in 2023, then slipped by 23 bps to 0.0% in 2024, then increased by 4 bps to 0.0% in 2025.
• The last three Return on Equity figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.